23 Jul, 2026
According to Straits Research, the global elastomeric infusion pump market size was valued at $688.38 million in 2025 and is projected to grow from $713.36 million in 2026 to $961.77 million by 2034, at a CAGR of 3.81% during the forecast period 2026–2034.
Elastomeric infusion pumps are non-electric, disposable pumps that administer regulated quantities of fluids, such as antibiotics, analgesics, and chemotherapeutic medications, into a patient's body. The elastomeric infusion pump is made of an elastic layer that provides the necessary pressure for medication administration. These pumps outperform traditional infusion pumps in mobility, practicality, and less room for human mistakes. Furthermore, these pumps do not rely on power or gravity. It may also be used for a variable period ranging from a few minutes to several days. Continuous rate pumps and variable rate pumps are the two forms of elastomer infusion pumps.
Elastomeric infusion pumps in the pain management, infection management, and chemotherapy market are observed to be highly competitive and comprise a large number of players. However, the market is currently dominated by a few players, such as B Braun Melsungen Ag, Baxter International Inc., and Promecon GmbH. The development of novel elastomer infusion pumps offers advanced features compared to conventional electronic pumps, such as portable, feasible, and low-cost devices, which drives the adoption of elastomer infusion pumps in the market. In addition, factors such as increased comfort, high patient satisfaction, and dose customization are expected to influence further the growth of novel elastomeric infusion pumps in the market. Thus, the development of novel elastomeric infusion pumps will drive the demand for elastomer infusion pumps.
Opportunities in untapped, emerging markets will likely drive the growth of the elastomer infusion pump market due to improved medical device industry infrastructure, a rise in medical device industries, and an increase in demand for elastomer infusion pump products. The healthcare industry in an emerging economy is developing significantly due to increased demand for better-advanced manufacturing systems and significant government investments to improve healthcare infrastructure. Moreover, emerging markets, such as China and India, are hubs of medical device companies, which will further contribute to the growth of this market.
The North America elastomeric infusion pump market accounted for a share of 39.73% in 2025 due to increasing use of disposable infusion systems in US correctional healthcare networks, where portable, tamper-resistant drug delivery is prioritized. Growing adoption within Native American tribal healthcare facilities and remote Canadian community care programs also supports demand due to limited access to electronic infusion infrastructure. Expanding use of elastomeric pumps in US clinical trial-based home infusion protocols is accelerating specialized outpatient deployment across precision oncology research programs.
The Asia Pacific elastomeric infusion pump market is expected to register the fastest regional growth with a CAGR of 6.71% during the forecast period, driven by increasing adoption of chemotherapy day-care centers in Japan and rising demand for battery-independent infusion devices across island-based healthcare networks in Indonesia and the Philippines. Expanding government-supported domestic medical device localization initiatives in China and India also supports market expansion. Overcrowded tertiary hospitals across major Asian cities are accelerating transition toward short-duration ambulatory infusion treatment models using disposable elastomeric systems.
sales@straitsresearch.com